These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 35442642)

  • 1. Pretargeted PET Imaging with a TCO-Conjugated Anti-CD44v6 Chimeric mAb U36 and [
    Lumen D; Vugts D; Chomet M; Imlimthan S; Sarparanta M; Vos R; Schreurs M; Verlaan M; Lang PA; Hippeläinen E; Beaino W; Windhorst AD; Airaksinen AJ
    Bioconjug Chem; 2022 May; 33(5):956-968. PubMed ID: 35442642
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting Infiltrating Myeloid Cells in Gastric Cancer Using a Pretargeted Imaging Strategy Based on Bio-Orthogonal Diels-Alder Click Chemistry and Comparison with
    Zhang Y; Lin Q; Wang T; Shi D; Fu Z; Si Z; Xu Z; Cheng Y; Shi H; Cheng D
    Mol Pharm; 2022 Jan; 19(1):246-257. PubMed ID: 34816721
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Performance of immuno-positron emission tomography with zirconium-89-labeled chimeric monoclonal antibody U36 in the detection of lymph node metastases in head and neck cancer patients.
    Börjesson PK; Jauw YW; Boellaard R; de Bree R; Comans EF; Roos JC; Castelijns JA; Vosjan MJ; Kummer JA; Leemans CR; Lammertsma AA; van Dongen GA
    Clin Cancer Res; 2006 Apr; 12(7 Pt 1):2133-40. PubMed ID: 16609026
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of the inverse electron demand Diels-Alder reaction in rats using a scandium-44-labelled tetrazine for pretargeted PET imaging.
    Edem PE; Sinnes JP; Pektor S; Bausbacher N; Rossin R; Yazdani A; Miederer M; Kjær A; Valliant JF; Robillard MS; Rösch F; Herth MM
    EJNMMI Res; 2019 May; 9(1):49. PubMed ID: 31140047
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radiation dosimetry of 89Zr-labeled chimeric monoclonal antibody U36 as used for immuno-PET in head and neck cancer patients.
    Börjesson PK; Jauw YW; de Bree R; Roos JC; Castelijns JA; Leemans CR; van Dongen GA; Boellaard R
    J Nucl Med; 2009 Nov; 50(11):1828-36. PubMed ID: 19837762
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Optimization of a Pretargeted Strategy for the PET Imaging of Colorectal Carcinoma via the Modulation of Radioligand Pharmacokinetics.
    Zeglis BM; Brand C; Abdel-Atti D; Carnazza KE; Cook BE; Carlin S; Reiner T; Lewis JS
    Mol Pharm; 2015 Oct; 12(10):3575-87. PubMed ID: 26287993
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Click-to-Release: Cleavable Radioimmunoimaging with [
    Vlastara M; Rossin R; Hoeben FJM; de Roode KE; Boswinkel M; Kleijn LHJ; Nagarajah J; Rijpkema M; Robillard MS
    Theranostics; 2023; 13(12):4004-4015. PubMed ID: 37554267
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-lived positron emitters zirconium-89 and iodine-124 for scouting of therapeutic radioimmunoconjugates with PET.
    Verel I; Visser GW; Boerman OC; van Eerd JE; Finn R; Boellaard R; Vosjan MJ; Stigter-van Walsum M; Snow GB; van Dongen GA
    Cancer Biother Radiopharm; 2003 Aug; 18(4):655-61. PubMed ID: 14503961
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of Structurally Diverse
    Adhikari K; Dewulf J; Vangestel C; Van der Veken P; Stroobants S; Elvas F; Augustyns K
    ACS Omega; 2023 Oct; 8(41):38252-38262. PubMed ID: 37867688
    [No Abstract]   [Full Text] [Related]  

  • 10. Improved stability of a novel fluorine-18 labeled TCO analogue for pretargeted PET imaging.
    Ruivo E; Adhikari K; Elvas F; Fissers J; Vangestel C; Staelens S; Stroobants S; Van der Veken P; Wyffels L; Augustyns K
    Nucl Med Biol; 2019; 76-77():36-42. PubMed ID: 31707309
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bioorthogonal Diels-Alder Click Chemistry-Based Pretargeted PET Imaging Strategy for Monitoring Programmed Death-Ligand 1 Expression.
    Huang Y; Li Z; Li C; Zang Z; Wang Q; Huang S; Liu Q; Liang Y
    ACS Omega; 2024 Sep; 9(35):36969-36981. PubMed ID: 39246495
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pretargeted Immuno-PET of Pancreatic Cancer: Overcoming Circulating Antigen and Internalized Antibody to Reduce Radiation Doses.
    Houghton JL; Zeglis BM; Abdel-Atti D; Sawada R; Scholz WW; Lewis JS
    J Nucl Med; 2016 Mar; 57(3):453-9. PubMed ID: 26471693
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantitative 89Zr immuno-PET for in vivo scouting of 90Y-labeled monoclonal antibodies in xenograft-bearing nude mice.
    Verel I; Visser GW; Boellaard R; Boerman OC; van Eerd J; Snow GB; Lammertsma AA; van Dongen GA
    J Nucl Med; 2003 Oct; 44(10):1663-70. PubMed ID: 14530484
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pretargeted PET of Osteodestructive Lesions in Dogs.
    Maitz CA; Delaney S; Cook BE; Genady AR; Hoerres R; Kuchuk M; Makris G; Valliant JF; Sadeghi S; Lewis JS; Hennkens HM; Bryan JN; Zeglis BM
    Mol Pharm; 2022 Sep; 19(9):3153-3162. PubMed ID: 35635337
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Site-specific conjugation allows modulation of click reaction stoichiometry for pretargeted SPECT imaging.
    Mandikian D; Rafidi H; Adhikari P; Venkatraman P; Nazarova L; Fung G; Figueroa I; Ferl GZ; Ulufatu S; Ho J; McCaughey C; Lau J; Yu SF; Prabhu S; Sadowsky J; Boswell CA
    MAbs; 2018; 10(8):1269-1280. PubMed ID: 30199303
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A pretargeted PET imaging strategy based on bioorthogonal Diels-Alder click chemistry.
    Zeglis BM; Sevak KK; Reiner T; Mohindra P; Carlin SD; Zanzonico P; Weissleder R; Lewis JS
    J Nucl Med; 2013 Aug; 54(8):1389-96. PubMed ID: 23708196
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Pretargeted Imaging Strategy for Immune Checkpoint Ligand PD-L1 Expression in Tumor Based on Bioorthogonal Diels-Alder Click Chemistry.
    Qiu L; Tan H; Lin Q; Si Z; Mao W; Wang T; Fu Z; Cheng D; Shi H
    Mol Imaging Biol; 2020 Aug; 22(4):842-853. PubMed ID: 31741201
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 89Zr immuno-PET: comprehensive procedures for the production of 89Zr-labeled monoclonal antibodies.
    Verel I; Visser GW; Boellaard R; Stigter-van Walsum M; Snow GB; van Dongen GA
    J Nucl Med; 2003 Aug; 44(8):1271-81. PubMed ID: 12902418
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Advancing
    Wuensche TE; Stergiou N; Mes I; Verlaan M; Schreurs M; Kooijman EJM; Janssen B; Windhorst AD; Jensen A; Asuni AA; Bang-Andersen B; Beaino W; Dongen GAMS; Vugts DJ
    Theranostics; 2022; 12(16):7067-7079. PubMed ID: 36276653
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibody-Based In Vivo Imaging of Central Nervous System Targets-Evaluation of a Pretargeting Approach Utilizing a TCO-Conjugated Brain Shuttle Antibody and Radiolabeled Tetrazines.
    Bredack C; Edelmann MR; Borroni E; Gobbi LC; Honer M
    Pharmaceuticals (Basel); 2022 Nov; 15(12):. PubMed ID: 36558900
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.